Sort
50,496 grants matching “lung cancer”
Dissemination and implementation of a corrective intervention to improve mediasti
$480,200Raymond U Osarogiagbon · University Of Memphis · R01 · FY2017 · CA
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$480,188Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2025 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$480,181James Hodge · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$480,181James W Hodge · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
EEG Biomarkers Derived from Dynamical Network Models Enable Rapid Paths to Accurate Diagnosis and Effective Treatment of Epilepsy
$480,149Sridevi V. Sarma · Johns Hopkins University · R35 · FY2023 · NS
Uncovering Oncogenotype-specific Vulnerabilities in Lung cancer
$480,137Jiyeon Kim · Yale University · R37 · FY2024 · CA
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer
$480,136Carol Ann Lange · University Of Minnesota · R01 · FY2023 · CA
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer
$480,136Carol Ann Lange · University Of Minnesota · R01 · FY2022 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$480,096John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Dissecting the interplay between aging, genotype and the microenvironment in lung cancer
$480,080Monte Meier Winslow · Stanford University · U01 · FY2021 · AG
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
$480,062Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Palliative Care: Maximizing Patient Preference
$480,056Donald H Taylor · Duke University · R01 · FY2011 · HS
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$480,000Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Phase I/II clinical evaluation of ABTL0812, a novel PI3K/Akt/mTOR inhibitor, with a unique mechanism of action inpancreatic cancer (Protocol sent on 20th June 2019 as an amendment of the IND 137394)
$480,000Davendra Sohal · University Of Cincinnati · R01 · FY2022 · FD
Redirected T Cell Therapy to Cure Invasive Fungal Infections
$480,000Dimitrios P Kontoyiannis · University Of Tx Md Anderson Can Ctr · R33 · FY2019 · AI
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes
$479,955Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Telomeres and lung cancer incidence and survival
$479,954Jennifer A. Doherty · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
Investigating the heterogeneity of glucose transport in lung adenocarcinoma
$479,942Claudio Scafoglio · University Of California Los Angeles · R01 · FY2024 · CA
Simultaneous dose and dose rate optimization for clinical FLASH proton radiotherapy
$479,938Hao Gao · University Of Kansas Medical Center · R01 · FY2024 · CA
Investigating the heterogeneity of glucose transport in lung adenocarcinoma
$479,934Claudio Scafoglio · University Of California Los Angeles · R01 · FY2025 · CA
Targeting Podoplanin to Prevent and Combat Oral Cancer
$479,927Gary S Goldberg · Rowan University School/Osteopathic Med · R15 · FY2019 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$479,843Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · CA
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
$479,803Phillip A Sharp · Massachusetts Institute Of Technology · R01 · FY2017 · CA
The nuclear Ferredoxin reductase and its role in tumor suppression
$479,793Xinbin Chen · University Of California At Davis · R01 · FY2025 · CA
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
$479,781Ann Marie Pendergast · Duke University · R01 · FY2022 · CA